ALK and non-small cell lung carcinoma: Ceritinib is used to treat anaplastic lymphoma kinase (ALK)-rearranged non-small cell lung cancer, which inhibits RANKL-induced phosphorylation of Akt and p65 in osteoclast and improves trabecular bone loss in OVX-mice (116).